BAGUIO CITY, Philippines — Investigation on massive corruption should expand from the Department of Public Works and Highways (DPWH) to the Department of Health (DOH), Mayor Benjamin Magalong said on ...

MANILA, Philippines — Baguio City Mayor Benjamin Magalong cried foul over a plot to ease him out of the Independent Commission for Infrastructure or ICI as he lamented a “deep seated” corruption in ...

MANILA, Philippines — Baguio City Mayor Benjamin Magalong, who recently resigned as special adviser to the Independent Commission for Infrastructure (ICI), believes that the commission tasked to look ...

MANILA, Philippines – The anti-corruption group Mayors for Good Governance (M4GG) reaffirmed Baguio City Mayor Benjamin “Benjie” Magalong’s clean track record following his recent resignation from the ...

MANILA, Philippines — Baguio City Mayor Benjamin Magalong resigned from his post as special adviser to the Independent Commission for Infrastructure (ICI) on Friday, citing actions from the Palace ...

Workers take a break at a construction site along Commonwealth Avenue in Quezon City, Jan. 30, 2025. — PHILIPPINE STAR/NOEL B. PABALATE THE Department of Labor and Employment (DoLE) will step in to ...

LC3-associated phagocytosis (LAP) is a specialized process for degrading dead cells, microbes or other particles. It plays a role in innate immunity, inflammation regulation and anticancer responses.

Four class I enzymes have been identified in humans and other mammals. These are divided into two subclasses (Ia and Ib) on the basis of their noncatalytic subunits. The Ia subgroup consists of the ...

Please provide your email address to receive an email when new articles are posted on . Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in ...

HOUSTON -- Two-thirds of patients with PI3K-mutant brain metastases responded to the maximum tolerated dose (MTD) of the small-molecule inhibitor paxalisib plus radiation therapy (RT), a small phase I ...

In the age of precision medicine, targeted drugs are transforming cancer treatment. But cancer cells persist in many patients, even in breast cancer, where much-lauded hormone therapies and targeted ...

With positive first-in-human findings on board, Relay Therapeutics Inc. plans a pivotal study next year to test RLY-2608, an allosteric, pan-mutant and isoform-selective inhibitor of PI3K alpha in ...